Kobayashi Tominari, Mikami Satoshi, Yokoyama Shigeyuki, Imataka Hiroaki
RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
J Virol Methods. 2007 Jun;142(1-2):182-8. doi: 10.1016/j.jviromet.2007.01.026. Epub 2007 Feb 23.
Cell-free synthesis of an infectious virus is an ideal tool for elucidating the mechanism of viral replication and for screening anti-viral drugs. In the present study, the synthesis of Encephalomyocarditis virus (EMCV) from its RNA in HeLa and 293-F cell extracts was enhanced by employing a dialysis system in combination with a ribozyme technology. Although translation and processing of the EMCV polyprotein were not accelerated greatly by the dialysis system, de novo synthesis of viral RNA was enhanced considerably by dialysis, leading to a greater than eight-fold increased titer of synthesized EMCV compared with a conventional batch system. Furthermore, a synthetic EMCV RNA with a hammerhead ribozyme sequence at its 5'-end served as an efficient template for viral synthesis in the dialysis system. Therefore, this system provides opportunities for mutational analyses of EMCV in vitro.
无细胞合成感染性病毒是阐明病毒复制机制和筛选抗病毒药物的理想工具。在本研究中,通过将透析系统与核酶技术相结合,在HeLa和293-F细胞提取物中从其RNA合成脑心肌炎病毒(EMCV)得到了增强。虽然透析系统并没有极大地加速EMCV多聚蛋白的翻译和加工,但透析显著增强了病毒RNA的从头合成,导致合成的EMCV滴度比传统批量系统提高了八倍以上。此外,在其5'端带有锤头状核酶序列的合成EMCV RNA在透析系统中作为病毒合成的有效模板。因此,该系统为体外对EMCV进行突变分析提供了机会。